RU2020113411A - Способы дифференцировки мезенхимальных стволовых клеток - Google Patents

Способы дифференцировки мезенхимальных стволовых клеток Download PDF

Info

Publication number
RU2020113411A
RU2020113411A RU2020113411A RU2020113411A RU2020113411A RU 2020113411 A RU2020113411 A RU 2020113411A RU 2020113411 A RU2020113411 A RU 2020113411A RU 2020113411 A RU2020113411 A RU 2020113411A RU 2020113411 A RU2020113411 A RU 2020113411A
Authority
RU
Russia
Prior art keywords
mscs
cells
cells derived
heparin
tgfβ
Prior art date
Application number
RU2020113411A
Other languages
English (en)
Russian (ru)
Other versions
RU2020113411A3 (https=
Inventor
Сандра ПЬЕТРИ
Сюань Май НГУЕН
Энрико БАСТЬЯНЕЛЛИ
Сабрина ЭНА
Пьер-Ив ЛАРЮЭЛЬ
Изабелла ТИТГАТ
Original Assignee
Боун Терапьютикс Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Боун Терапьютикс Са filed Critical Боун Терапьютикс Са
Publication of RU2020113411A3 publication Critical patent/RU2020113411A3/ru
Publication of RU2020113411A publication Critical patent/RU2020113411A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/91—Heparin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
RU2020113411A 2017-10-20 2018-09-25 Способы дифференцировки мезенхимальных стволовых клеток RU2020113411A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17197605.3 2017-10-20
EP17197605 2017-10-20
PCT/EP2018/076030 WO2019076591A1 (en) 2017-10-20 2018-09-25 METHODS FOR DIFFERENCING MESENCHYMAL STEM CELLS

Publications (2)

Publication Number Publication Date
RU2020113411A3 RU2020113411A3 (https=) 2021-11-22
RU2020113411A true RU2020113411A (ru) 2021-11-22

Family

ID=60153205

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2020113411A RU2020113411A (ru) 2017-10-20 2018-09-25 Способы дифференцировки мезенхимальных стволовых клеток

Country Status (13)

Country Link
US (2) US11447749B2 (https=)
EP (1) EP3697894A1 (https=)
JP (1) JP7039711B2 (https=)
KR (1) KR102185697B1 (https=)
CN (1) CN111247240A (https=)
AU (1) AU2018351804B2 (https=)
BE (1) BE1025935A9 (https=)
BR (1) BR112020007775A2 (https=)
CA (1) CA3079439C (https=)
IL (1) IL273987B (https=)
RU (1) RU2020113411A (https=)
SG (1) SG11202003524XA (https=)
WO (1) WO2019076591A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2823290C1 (ru) * 2023-11-20 2024-07-22 Федеральное государственное бюджетное учреждение "Федеральный научно-клинический центр физико-химической медицины им. академика Ю. М. Лопухина" Федерального Медико-биологического агентства Улучшенный способ дифференцировки индуцированных плюрипотентных стволовых клеток человека в дофаминэргические нейроны

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1026595B9 (fr) * 2018-09-25 2020-11-03 Bone Therapeutics Sa Procedes de differenciation de cellules souches mesenchymateuses
CN113648417A (zh) * 2021-03-15 2021-11-16 中国人民解放军军事科学院军事医学研究院 Postn作为调控间充质干细胞分化能力的标志物及其应用
CN113355279A (zh) * 2021-06-07 2021-09-07 深圳市中佳生物医疗科技有限公司 一种人韧带成纤维细胞的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764369A (en) 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5972703A (en) 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
AU2003202988A1 (en) 2002-01-14 2003-07-30 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
CA2640794C (en) 2006-02-16 2015-04-14 Universite Libre De Bruxelles A method for osteogenic differentiation of bone marrow stem cells (bmsc) and uses thereof
WO2008129563A2 (en) * 2007-04-23 2008-10-30 Stempeutics Research Private Limited, Human mesenchymal stem cells and preparation thereof
US20100278788A1 (en) 2008-01-11 2010-11-04 Bone Therapeutics, S.A. Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
HK1202581A1 (en) 2012-02-13 2015-10-02 Gamida-Cell Ltd. Mesenchymal stem cells conditioned medium and methods of generating and using the same
EP2943206A4 (en) * 2013-01-12 2017-01-04 Cesca Therapeutics Inc. Rapid infusion of autologous bone marrow derived stem cells
EP3074505B1 (en) 2014-02-14 2018-06-06 National University of Ireland Galway Serum-free medium
JP6446222B2 (ja) * 2014-09-30 2018-12-26 株式会社ジーシー 軟骨分化培養液、及び軟骨組織の製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2823290C1 (ru) * 2023-11-20 2024-07-22 Федеральное государственное бюджетное учреждение "Федеральный научно-клинический центр физико-химической медицины им. академика Ю. М. Лопухина" Федерального Медико-биологического агентства Улучшенный способ дифференцировки индуцированных плюрипотентных стволовых клеток человека в дофаминэргические нейроны

Also Published As

Publication number Publication date
BE1025935B9 (fr) 2019-10-29
JP7039711B2 (ja) 2022-03-22
AU2018351804B2 (en) 2020-07-09
JP2020537539A (ja) 2020-12-24
US20230042822A1 (en) 2023-02-09
BE1025935A1 (fr) 2019-08-13
SG11202003524XA (en) 2020-05-28
BE1025935A9 (fr) 2019-11-05
CN111247240A (zh) 2020-06-05
CA3079439A1 (en) 2019-04-25
EP3697894A1 (en) 2020-08-26
US11447749B2 (en) 2022-09-20
US20200354682A1 (en) 2020-11-12
IL273987B (en) 2021-06-30
AU2018351804A1 (en) 2020-05-14
BE1025935B1 (fr) 2019-10-18
KR102185697B1 (ko) 2020-12-03
RU2020113411A3 (https=) 2021-11-22
IL273987A (en) 2020-05-31
KR20200063241A (ko) 2020-06-04
WO2019076591A1 (en) 2019-04-25
CA3079439C (en) 2022-08-09
BR112020007775A2 (pt) 2020-10-20

Similar Documents

Publication Publication Date Title
Alves da Silva et al. Chondrogenic differentiation of human bone marrow mesenchymal stem cells in chitosan‐based scaffolds using a flow‐perfusion bioreactor
CN1961069A (zh) 获得间充质干细胞的方法
Ponnaiyan et al. Comparison of phenotype and differentiation marker gene expression profiles in human dental pulp and bone marrow mesenchymal stem cells
RU2020113411A (ru) Способы дифференцировки мезенхимальных стволовых клеток
Singh et al. Directing chondrogenesis of stem cells with specific blends of cellulose and silk
van der Smissen et al. Growth promoting substrates for human dermal fibroblasts provided by artificial extracellular matrices composed of collagen I and sulfated glycosaminoglycans
JP2013507931A (ja) 再生医療用途のための接着性骨髄幹細胞の閉鎖系統分離システム
Lai Biofunctionalization of gelatin microcarrier with oxidized hyaluronic acid for corneal keratocyte cultivation
WO2015033558A1 (ja) 多能性幹細胞の調製方法
Yang et al. Osteodifferentiation of mesenchymal stem cells on chitosan/hydroxyapatite composite films
HK1212382A1 (en) Differentiation of human fibroblast cells
CN113056557A (zh) 用于分化间充质干细胞的方法
Schmidt et al. Low, medium, and high molecular weight hyaluronic acid effects on human dental pulp stem cells in vitro
CN105039248A (zh) 树鼩骨髓间充质干细胞培养系统
CN105602893A (zh) 一种无血清培养脐带间充质干细胞方法及应用
Kiany et al. Bone repair potential of collagen-poly (3-hydroxybutyrate)-carbon nanotubes scaffold loaded with mesenchymal stem cells for the reconstruction of critical-sized mandibular defects
CN113425619A (zh) 一种间充质干细胞分泌因子的纯化制备方法及用途
TWI419970B (zh) 使成體幹細胞產生為一球體細胞群體的方法
CN117089517A (zh) 用于增强间充质干细胞免疫抑制能力和抗衰老能力的方法
Song et al. Plasma fibrin membranes loaded with bone marrow mesenchymal stem cells and corneal epithelial cells promote corneal injury healing via attenuating inflammation and fibrosis after corneal burns
JP2020537539A5 (https=)
Kulikouskaya et al. Polydimethylsiloxane films modified with chitosan/pectin multilayers as scaffolds for mesenchymal stem cells
Calabrese et al. Silk–ionomer and silk–tropoelastin hydrogels as charged three‐dimensional culture platforms for the regulation of hMSC response
Nagakura et al. Effect of viscous injectable pure alginate sol on cultured fibroblasts
CN111979186B (zh) 一种快速高效体外扩增人间充质干细胞的方法及应用